Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
ConclusionCebranopadol may have significant potential for the treatment of various pain types, including inflammatory and chemotherapy-induced neuropathic pain.
Source: Inflammopharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemistry | Chemotherapy | Cholesterol | Chronic Pain | Clinical Trials | Diabetes | Drugs & Pharmacology | Eloxatin | Endocrinology | Morphine | Neurology | Pain | Simvastatin | Statin Therapy | Study | Zocor